Early Intervention in Ischemic Tissue with Oxygen Nanocarriers Enables Successful Implementation of Restorative Cell Therapies.

Ludmila Diaz-StarokozhevaDevleena DasXiangming GuJordan T MooreLuke R LemmermanIan ValerioHeather M PowellNatalia Higuita-CastroMichael R GoAndre F PalmerDaniel Gallego Perez

Published in: Cellular and molecular bioengineering (2020)

These results indicate that PolyHb and TNT technologies could potentially be synergistically deployed and used as early intervention measures to combat severe tissue ischemia.

Keyphrases

randomized controlled trial
drug delivery
primary care
healthcare
single cell
cell therapy
early onset
quality improvement
drug release
ischemia reperfusion injury
bone marrow
subarachnoid hemorrhage